COVID-19SERIES OF

WEBINARS https://covid19.ser.es/

Sponsored by:

ScientificCommittee

www.ser.es

Miguel Ángel Abad HernándezHospital Virgen del Puerto, Cáceres, Spain

José Mª Álvaro-Gracia Álvaro President of Spanish Society of Rheumatology.Hospital General Universitario Gregorio Marañón, Madrid, Spain

Loreto Carmona OrtellsInstituto de Salud Musculoesquelética, Madrid, Spain

Ramón Mazzucchelli EstebanHospital Universitario Fundación Alcorcón, Madrid, Spain Raimon Sanmartí SalaHospital Universitario Clínic de Barcelona, Spain

https://covid19.ser.es/

COVID-19SERIES OF

WEBINARS

THURSDAY 11TH JUNE | 16.30-18.20 H WEBINAR. COVID-19: AN OVERVIEW

TUESDAY 16TH JUNE | 16.30-18.10 H WEBINAR. COVID-19: CLINICAL

MANIFESTATIONS16.30-16.35 h Introduction

José Mª Álvaro-GraciaPresident of Spanish Society of Rheumatology.Hospital General Universitario Gregorio Marañón, Madrid, Spain

16.35-16.50 h SARS-CoV-2: the virusAna Fernández-Sesma Icahn School of Medicine at Mount Sinai, New York, USA

16.50-17.05 h COVID-19. Hopes on therapy?Adolfo García-SastreGlobal Health and Emerging Pathogens Institute. Icahn School of Medicineat Mount Sinai, New York, USA

17.05-17.20 h Discussion

17.20-17.35 h Physiopathology of SARS-CoV-2 infectionBin CaoChina-Japan Friendship Hospital, Beijing, China

17.35-17.50 h Hypercoagulability in COVID-19Jean M. ConnorsBrigham and Women's Hospital. Harvard Medical School, Boston, USA

17.50-18.05 h Diagnosis of COVID-19. What test and what for? Jordi Vila Hospital Universitario Clínic de Barcelona, Spain

18.05-18.20 h Discussion

16.30-16.35 h IntroductionMª José Cuadrado Clínica Universidad de Navarra, Madrid, Spain

16.35-16.50 h Clinical manifestations and poor prognosis factors in COVID-19

Alex SorianoHospital Universitario Clínic de Barcelona. Universitat de Barcelona-IDIBAPS,Barcelona, Spain

16.50-17.05 h COVID-19 and the heartMarco MetraUniversità degli Studi di Brescia, Brescia, Italy

17.05-17.15 h Skin manifestations of COVID-19 infectionIgnacio García-DovalComplejo Hospitalario Universitario de Pontevedra, Spain

17.15-17.25 h Neurological manifestations of COVID-19 infection David García-AzorínHospital Clínico Universitario de Valladolid, Spain

17.25-17.35 h Kidney involvement in COVID-19 Almudena VegaHospital General Universitario Gregorio Marañón, Madrid, Spain

17.35-17.50 h Use of renin-angiotensin inhibitors and risk of COVID19Francisco de AbajoHospital Universitario Príncipe de Asturias. Universidad de Alcalá, Madrid, Spain

17.50-18.10 h Discussion

Chair:

José Mª Álvaro-GraciaChair:

Mª José Cuadrado

https://covid19.ser.es/https://covid19.ser.es/

Chair:

Loreto Carmona

TUESDAY 23RD JUNE | 16.30-18.10 H WEBINAR. COVID-19:

IN SEARCH OF THERAPY16.30-16.35 h Introduction

Loreto Carmona Instituto de Salud Musculoesquelética, Madrid, Spain

16.35-16.50 h A matter of curves Aurelio Tobías Instituto de Evaluación Ambiental e Investigación del Agua (IDAEA).Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, Spain

16.50-17.05 h How to control a pandemic Helena Legido-Quigley Saw Swee Hock School of Public Health. National University of Singapore

17.05-17.35 h Vaccines17.05-17.15 h Mariano Esteban Consejo Superior de Investigaciones Científicas (CSIC) y Centro Nacional de Biotecnología (CNB), Madrid, Spain

17.15-17.25 h Luis Enjuanes Consejo Superior de Investigaciones Científicas (CSIC) y Centro Nacional de Biotecnología (CNB), Madrid, Spain

17.25-17.35 h Adrian Hill The Jenner Institute. University of Oxford, UK

17.35-17.45 h Chemoprophylaxis (colchicine, antimalarials and antivirals)

Bonaventura ClotetHospital Universitario Germans Trias i Pujol, Barcelona, Spain

17.45-17.55 h Availability of vaccines in the worldDavid M. Salisbury Royal Institute of International Affairs, Chatham House, London, UK

17.55-18.15 h Discussion

16.30-16.35 h IntroductionRaimon SanmartíHospital Universitario Clínic de Barcelona, Spain

16.35-16.50 h Searching for targets in artificial intelligence timeJustin Stebbing Imperial College, London, UK

16.50-17.00 h Role of antivirals (remdesivir, lopinavir-ritonavir interferon)

José M. Miró Hospital Universitario Clínic de Barcelona, Spain

17.00-17.10 h Antimalarials in SARS-CoV-2 infection

Saint-Antoine Hospital, Paris, France

17.10-17.20 h More randomized control trials, pleaseCésar Hernández Agencia Española del Medicamento, Madrid, Spain

17.20-17.35 h Role of biological agents in the treatment of COVID-19 Carlo Salvarani University of Modena and Reggio Emilia, Modena, Italy

17.35-17.50 h Non-biological anti-inflammatory agents in the treatment of COVID-19

Fabrizio Cantini Nuovo Ospedale di Prato - Presidio "Misericordia e Dolce", Prato, Italy

17.50-18.10 h Discussion

Chair:

Raimon Sanmartí

THURSDAY 18TH JUNE | 16.30-18.15 H WEBINAR. COVID-19: EPIDEMIOLOGY AND PREVENTION

https://covid19.ser.es/ https://covid19.ser.es/

Francis Berenbaum

THURSDAY 25TH JUNE | 16.30-18.10 H WEBINAR. COVID-19:IN RHEUMATOLOGY

Juan J. Gómez-Reino

16.30-16.35 h IntroductionJuan J. Gómez-ReinoFundación Ramón Domínguez. Hospital Clínico Universitario de Santiago, Spain

16.35-16.50 h Risk of COVID-19 in rheumatic diseasesJosé Luis Pablos Hospital Universitario 12 de Octubre, Madrid, Spain

16.50-17.05 h COVID-19 Global Rheumatology Alliance. Evolution of rheumatic patients with COVID-19 Pedro Machado University College London, UK

17.05-17.20 h Managing rheumatic patients in COVID-19 times José Mª Álvaro-GraciaPresident of Spanish Society of Rheumatology.Hospital General Universitario Gregorio Marañón, Madrid, Spain

17.20-17.35 h The impact of COVID-19 in rheumatology. An opportunity for change?Iain B McInnes

https://covid19.ser.es/

COVID-19SERIES OF

WEBINARS

17.35-17.50 h No more pandemics, thank youPedro AlonsoWorld Health Organization's World Malaria Programme, Geneva, Switzerland

17.50-18.10 h Discussion

EULAR PresidentInstitute of Infection, Immunity and Inflammation. University of Glasgow, UK

Chair:

www.ser.es

https://covid19.ser.es/

Sponsored by: